Combinatorial approaches to formulation development

Current Opinion in Drug Discovery and Development

Volumn 4, Issue 4, 2001, Pages 493-501

  Alakhov, V ^a   Pietrzynski, G ^a   Kabanov, A ^a  

^a Supratek Pharma Inc   (Canada)

Author keywords

Block copolymers; Combinatorial methods; Drug formulation; Libraries of carriers; Micelles; QSPR; Screening

Indexed keywords

ANTINEOPLASTIC AGENT; COPOLYMER; DRUG CARRIER; ESTRADIOL; GENTAMICIN; LEUPRORELIN; MACROGOL; METOCLOPRAMIDE; POLY(2 VINYL 2 PYRROLIDONE); POLY(BETA BENZYLASPARTATE); POLY(BETAL BENZYLGLUTAMATE); POLYACRYLIC ACID; POLYASPARTIC ACID; POLYCAPROLACTONE; POLYETHYLENEIMINE; POLYGLACTIN; POLYGLUTAMIC ACID; POLYLYSINE; POLYMER; POLYPROPYLENE OXIDE; POLYSORBATE; POLYSTYRENE; POLYVINYL ALCOHOL; POVIDONE; PRIMAQUINE; SALBUTAMOL; SURFACTANT; UNCLASSIFIED DRUG;

CONTROLLED DRUG RELEASE; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; LIPOPHILICITY; METHODOLOGY; OSTEOMYELITIS; PHARMACOPHORE; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; HUMANS;

EID: 0034911512     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. General method for rapid synthesis of multicomponent peptide mixtures
2. From peptides to drugs via phage display
3. Comprehensive survey of combinatorial library synthesis: 1998
4. Drug discovery: A historical perspective
5. Combinatorial drug discovery: Concepts
6. A combinatorial approach for polymer design
7. Combinatorial materials and catalyst research
8. Drug screening-beyond the bottleneck
9. New assay technologies for high-throughput screening
10. Printing small molecules as microarrays and detecting protein-ligand interactions en masse
11. New methods in combinatorial chemistry - Robotics and parallel synthesis
12. Designing diverse and focused combinatorial libraries of synthetic polymers
13. QSPR: The correlation and quantitative prediction of chemical and physical properties from structure
14. Forecasting the in vivo performance of four low solubility drugs from their in vitro dissolution data
15. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel
16. Podophyllotoxin
17. Therapeutic applications of colloidal drug carriers
18. Improving drug solubility for oral delivery using solid dispersions
19. Solubilization of hydrocarbons and resulting aggregate shape transitions in aqueous solutions of pluronic (PEO-PPO-PEO) block copolymers
20. Determination of the aqueous solubility of drugs using a convenient 96-well plate-based assay
21. Relationship between polysorbate 80 solubilization descriptors and octanol-water partition coefficients of drugs
22. Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials
23. Effect of some physical parameters on the sustained drug-release properties of substituted amylose matrices
24. Effect of formulation and process variables on porosity parameters and release rates from a multi unit erosion matrix of a poorly soluble drug
25. Captopril gastrointestinal therapeutic system coated with cellulose acetate pseudolatex: Evaluation of main effects of several formulation variables
26. Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide
27. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres
28. Formulation optimization of controlled-release pellets of metoclopramide hydrochloride using dissolution fit factor approach
29. Formulation of calcium phosphates/poly(D,L-lactide) blends containing gentamicin for bone implantation
30. Controlled release of β-estradiol from PLAGA microparticles: The effect of organic phase solvent on encapsulation and release
31. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations
32. Gastrointestinal absorption of drugs: Methods and studies
33. QSAR model for drug human oral bioavailability
34. An integrated model for determining causes of poor oral drug absorption
35. Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts
36. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs
37. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats
38. Multivariate methods in developing an evolutionary strategy for tablet formulation
39. Formulation and characterization of primaquine loaded liposomes prepared by a pH gradient using experimental design
40. Formulation optimization technique based on artificial neural network in salbutamol sulfate osmotic pump tablets
41. Optimization study on the formulation of roxithromycin dispersible tablet using experimental design
42. Quantitative component analysis of mixtures for risk assessment: Application to eye irritation
43. Block copolymeric biotransport carriers as versatile vehicles for drug delivery
44. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer
45. Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: In vivo evaluation of anti-cancer activity
46. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells
47. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers
48. Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers
49. Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells
50. Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers
51. A combination of polyoxamers increases gene expression of plasmid DNA in skeletal muscle
52. Block copolymeric biotransport carriers as versatile vehicles for drug delivery
53. Polycaprolactone-β-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone
54. Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(D,L-lactide) block copolymers as potential drug carrier
55. Synthesis and characterization of model polyalkane-poly(ethylene oxide) block copolymers
56. Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen
57. Novel polymeric micelles based on the amphiphilic block copolymer poly(N-vinyl-2-pyrrolidone)-block-poly(D,L-lactide)
58. Block copolymer micelles for drug delivery: Loading and release of doxorubicin
59. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(β-benzyl-L-aspartate) block copolymer micelles
60. Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolides) facilitate the preparation of small negatively charged biodegradable nanospheres
61. Novel family of thermogelling materials via C-C bonding between poly(acrylic acid) and poly(ethylene oxide)-β-poly(propylene oxide)-β-poly(ethylene oxide)
62. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer
63. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents
64. Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol)-poly(L-lysine) block copolymer
65. Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides
66. Block copolymer micelles as long-circulating drug vehicles
67. Self-assembly in aqueous solutions of poly(ethylene oxide)-β-poly(propylene oxide)-β-poly(ethylene oxide)-β-poly(vinyl alcohol)
68. Biodegradable thermosensitive micelles of PEG-PLGA-PEG triblock copolymers
69. New biodegradable polymers for injectable drug delivery systems
70. The dynamic mean-field density functional method and its application to the mesoscopic dynamics of quenched block copolymer melts
71. The MesoDyn project: Software for mesoscale chemical engineering
72. Dissipative particle dynamics: Bringing the gap between atomistic and mesoscopic simulation
73. Comparison of nephrotoxicities of different polyoxyethyleneglycol formulations of amphotericin B in rats
74. Poorly soluble drugs, a challenge in drug delivery
75. 14C] thymidine uptake in cultured human cancer cells
76. Uridine uptake inhibition as a cytotoxicity test for a human hepatoma cell line (HepG2 cells): Comparison with the neutral red assay
77. Caco-2 monolayers in experimental and theoretical prediction of drug transport
78. A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 1: System characterization
79. Brain microvessel endothelial cell culture systems
80. Transport of cationized anti-tetanus Fab'2 fragments across an in vitro blood-brain barrier model: Involvement of the transcytosis pathway
81. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly